GSK senior VP-worldwide development
Executive Summary
AstraZeneca Senior VP-U.S. Drug Development Ronald Krall, MD, joins GlaxoSmithKline as senior VP-worldwide development, research & development, effective Feb. 19. Krall succeeds James Palmer, MD, who served as senior VP-new product development and left GSK in October to become Bristol Myers-Squibb chief scientific officer (1"The Pink Sheet" Oct. 28, 2002, p. 15). AstraZeneca VP-Clinical Development Glenn Gormley, MD, is succeeding Krall on an acting basis....